133 related articles for article (PubMed ID: 36921745)
1. Design and biological evaluation of Repaglinide loaded polymeric nanocarriers for diabetes linked neurodegenerative disorder: QbD-driven optimization, in situ, in vitro and in vivo investigation.
Wadhwa G; Venkata Krishna K; Kumar Dubey S; Taliyan R
Int J Pharm; 2023 Apr; 636():122824. PubMed ID: 36921745
[TBL] [Abstract][Full Text] [Related]
2. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
3. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and
Wu L; Zhao L; Su X; Zhang P; Ling G
Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898
[TBL] [Abstract][Full Text] [Related]
4. Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: in vitro and in vivo studies.
Vijayan V; Reddy KR; Sakthivel S; Swetha C
Colloids Surf B Biointerfaces; 2013 Nov; 111():150-5. PubMed ID: 23792547
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
6. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
7. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
[TBL] [Abstract][Full Text] [Related]
8. Optimisation and evaluation of
Dewangan HK; Singh N; Kumar Megh S; Singh S; Lakshmi
J Microencapsul; 2022 Mar; 39(2):125-135. PubMed ID: 35282781
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Drug Delivery of Frovatriptan Succinate-Loaded Polymeric Nanoparticles for Brain Targeting.
Deepika D; Dewangan HK; Maurya L; Singh S
J Pharm Sci; 2019 Feb; 108(2):851-859. PubMed ID: 30053555
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
Jain A; Sharma T; Kumar R; Katare OP; Singh B
Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
[TBL] [Abstract][Full Text] [Related]
11. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
Dhal C; Mishra R
Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
[TBL] [Abstract][Full Text] [Related]
12. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
[TBL] [Abstract][Full Text] [Related]
13. Biotinylated HPMA centered polymeric nanoparticles for Bortezomib delivery.
Rani S; Sahoo RK; Nakhate KT; Ajazuddin ; Gupta U
Int J Pharm; 2020 Apr; 579():119173. PubMed ID: 32097684
[TBL] [Abstract][Full Text] [Related]
14. Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery.
Krishna KV; Wadhwa G; Alexander A; Kanojia N; Saha RN; Kukreti R; Singhvi G; Dubey SK
ACS Chem Neurosci; 2019 Sep; 10(9):4124-4135. PubMed ID: 31418556
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer.
Bhaskaran NA; Jitta SR; Salwa ; Kumar L; Sharma P; Kulkarni OP; Hari G; Gourishetti K; Verma R; Birangal SR; Bhaskar KV
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127142. PubMed ID: 37797853
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
[TBL] [Abstract][Full Text] [Related]
17. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses.
Guo Z; Afza R; Moneeb Khan M; Khan SU; Khan MW; Ali Z; Batool S; Din FU
Heliyon; 2023 Sep; 9(9):e20107. PubMed ID: 37810010
[TBL] [Abstract][Full Text] [Related]
20. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
